by Clinical Neuropsychologist Online | Friday, August 14, 2026 | Dementia
Abstract INTRODUCTION Amyloid-lowering antibodies are associated with neuroanatomical volume changes. This study aims to disentangle the contributions of amyloid-related imaging abnormalities (ARIA) and amyloid clearance to these changes. METHODS Data from the...
by Clinical Neuropsychologist Online | Friday, August 14, 2026 | Dementia
Abstract INTRODUCTION Astrocyte dysfunction is central to Alzheimer’s disease (AD), yet expression patterns of astrocytic markers remain poorly defined. We measured Aquaporin-4 (AQP4) and glial fibrillary acidic protein (GFAP) in post-mortem frontal cortex of AD...
by Clinical Neuropsychologist Online | Friday, August 14, 2026 | Dementia
Dementia, Ahead of Print. Non-pharmacological interventions are widely recognised as essential components of dementia care. However, many cognitive activities lack cultural relevance and are difficult to integrate into everyday care practice. Design-driven approaches...
by Clinical Neuropsychologist Online | Thursday, August 13, 2026 | Dementia
Abstract INTRODUCTION APOE ε4 is the strongest common genetic risk factor for Alzheimer’s disease (AD), yet many carriers remain cognitively unimpaired into late life. We tested whether protected ε4-first plasma proteomics could identify proteins associated with...
by Clinical Neuropsychologist Online | Thursday, August 13, 2026 | Paediatric Neuropsychology
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | August 13, 2026 Neuro-Paediatric Previous Page
